Chengdu SciMount Pharmatech Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Chengdu SciMount Pharmatech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| SMP-656 for HER2-Positive Advanced Breast Cancer (NCT07726342) | Chengdu SciMount Pharmatech Co., Ltd. | 2026-07-16 |
| 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability (NCT05029518) | Chengdu SciMount Pharmatech Co., Ltd. | 2021-09-09 |
| A Phase 1 Study of SMP-100 in Normal Healthy Volunteers (NCT04296799) | Chengdu SciMount Pharmatech Co., Ltd. | 2020-06-25 |
Track Chengdu SciMount Pharmatech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.